MyFinsight
Home
Blog
About
Back
Income Statement
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)
source: myfinsight.com
Total comprehensive
loss
-$6,382,000
(6.61%↑ Y/Y)
Net loss
-$6,375,000
(6.55%↑ Y/Y)
Total other
comprehensive loss
-$7,000
(41.67%↑ Y/Y)
Foreign currency
translation adjustments
$5,000
(120.83%↑ Y/Y)
Loss from operations
-$6,076,000
(11.57%↑ Y/Y)
Other (expense)
income, net
-$299,000
(-710.20%↓ Y/Y)
Unrealized (gain) loss on
investments, net of tax of 0
-$12,000
(-200.00%↓ Y/Y)
Total operating
expenses
$6,076,000
(-11.57%↓ Y/Y)
Research and development
$3,638,000
(-15.24%↓ Y/Y)
General and
administrative
$2,438,000
(-5.47%↓ Y/Y)
Back